Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/10/2012US20120114625 Shelf-stable fermented dairy products and methods of making same
05/10/2012US20120114611 Bacteriophage-containing therapeutic agents
05/10/2012US20120114605 Methods and compositions relating to hematologic malignancies
05/10/2012US20120114604 Combinations for HCV Treatment
05/10/2012US20120114602 Process for the synthesis of conjugates of glycosaminoglycanes (gag) with biologically active molecules, polymeric conjugates and relative uses thereof
05/10/2012US20120114601 New isothiazoloquinolones and related compounds as anti-infective agents
05/10/2012US20120114600 Novel inhibitors of hepatitis c virus
05/10/2012US20120114599 Opioid and opioid-like compounds and uses thereof
05/10/2012US20120114596 Tslp promotes immune evasion and persistence of viruses
05/10/2012US20120114591 Treatment of chronic ulcerous skin lesions
05/10/2012US20120114588 Ibat inhibitors for treatment of metabolic disorders and related conditions
05/10/2012US20120114574 Compositions for nail and skin treatment
05/10/2012US20120114572 Photostabilization of coenzyme Q compounds with alkoxycrylene compounds
05/10/2012US20120114566 Lipoxin analogs and methods for the treatment of periodontal disease
05/10/2012US20120114558 Aptamer-mediated drug release
05/10/2012US20120114556 Immunotherapy of autoimmune disorders using antibodies which target b-cells
05/10/2012US20120111756 Enema formulations
05/10/2012US20120111324 Dry Powder Drug Delivery Formulations, Methods of Use, and Devices Therefore
05/10/2012DE102010050570A1 Zusammensetzung und Arzneimittel enthaltend ω-3-Fettsäuren sowie einen Inhibitor des NF-κB-Transkriptionsfaktors Composition and medicines containing ω-3 fatty acids as well as an inhibitor of NF-kB transcription factor
05/10/2012DE102010050558A1 1H-Pyrrolo[2,3-b]pyridinderivate 1H-pyrrolo [2,3-b] pyridine
05/10/2012DE102010048800A1 Chinoxalinderivate Quinoxaline derivatives
05/10/2012DE102010043380A1 Benzyl-substituierte Carbamate und ihre Verwendung Benzyl-substituted carbamates and their use
05/10/2012DE102010043379A1 Substituierte 6-Fluor-1H-Pyrazolo[4,3-b]pyridine und ihre Verwendung Substituted 6-fluoro-1H-pyrazolo [4,3-b] pyridines and their use
05/10/2012CA2829117A1 Novel 6-arylamino pyridone carboxamide as mek inhibitors
05/10/2012CA2819997A1 Preventive or therapeutic agent for pain associated with herpes zoster in acute phase
05/10/2012CA2816963A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
05/10/2012CA2816957A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816949A1 Methods of treatment using lipid compounds
05/10/2012CA2816929A1 Synthetic lethality in cancer
05/10/2012CA2816911A1 Novel treatment of multiple sclerosis (ms)
05/10/2012CA2816896A1 1h-pyrrolo[2,3-b]pyridine derivatives
05/10/2012CA2816884A1 Articles incorporating absorbert polymer and ceragenin compound
05/10/2012CA2816872A1 Composition and method for treating skin conditions
05/10/2012CA2816855A1 Combination therapy for prostate cancer using botanical compositions and bicalutamide
05/10/2012CA2816839A1 Peg or peg block copolymers for treating colorectal cancer
05/10/2012CA2816835A1 Formulations comprising polyethylene glycol
05/10/2012CA2816834A1 A2a antagonists as cognition and motor function enhancers
05/10/2012CA2816710A1 Compositions and methods for treating myelofibrosis
05/10/2012CA2816671A1 Substituted 6-fluoro-1h-pyrazolo[4,3-b]pyridines and use thereof
05/10/2012CA2816670A1 Organic amine salts of aminobenzoic acid derivatives and method for producing same
05/10/2012CA2816639A1 Benzyl-substituted carbamates and use thereof
05/10/2012CA2816551A1 Method of treating mucosal inflammation
05/10/2012CA2816515A1 Process for the preparation of phosphoric acid mono-(1-{4-[(s)-5-(acetylaminomethyl)-2-oxo-oxazolidin-3-yl]-2,6-difluorophenyl}-4-methoxymethylpiperidin-4-yl) ester
05/10/2012CA2816363A1 7-(1,2,3-triazol-4-yl)pyrrolo[2,3-b]pyrazine derivatives
05/10/2012CA2816322A1 Isoflavonoid compositions and methods for the treatment of cancer
05/10/2012CA2816319A1 Isoflavonoid compounds and methods for the treatment of cancer
05/10/2012CA2816258A1 Method for decontaminating starch hydrolysates for the preparation of glucose polymers for peritoneal dialysis
05/10/2012CA2816219A1 Benzamides and nicotinamides as syk modulators
05/10/2012CA2816181A1 Dihydrooxazol-2-amine derivatives
05/10/2012CA2816136A1 Crystalline forms of hydrochloride salt of (4a-r,9a-s) -1- (1h - benzoimidazole- 5 -carbonyl) -2, 3, 4, 4a, 9, 9a - hexahydro -1h- indeno [2, 1 -b] pyridine- 6 -carbonitrile and their use as hsd 1 inhibitors
05/10/2012CA2816123A1 Compositions and methods for the delivery of therapeutics
05/10/2012CA2816121A1 System and method for delivery of dna-binding chemotherapy drugs using nanoparticles
05/10/2012CA2816077A1 Pharmaceutical compositions
05/10/2012CA2816076A1 Pesticidal compositions and processes related thereto
05/10/2012CA2816027A1 Magnetic targeting device, system and method
05/10/2012CA2815964A1 Trans-2-decenoic acid derivative and pharmaceutical agent containing the same
05/10/2012CA2815959A1 Accordion pill comprising levodopa for an improved treatment of parkinson's disease symptoms
05/10/2012CA2815858A1 Heterocyclic compounds and uses thereof
05/10/2012CA2815855A1 Novel specific hcv ns3 protease inhibitors
05/10/2012CA2815832A1 Pesticidal compositions and processes related thereto
05/10/2012CA2815792A1 Felbinac-containing external patch
05/10/2012CA2815781A1 Dynamic balancing of autonomic nervous system through vitamin mk-7
05/10/2012CA2815611A1 Pyrrolidine derivatives used as cathepsin inhibitors
05/10/2012CA2815445A1 5 -cyano-4, 6 -diaminopyrimidine or 6 -aminopurine derivatives as pi3k-delta inhibitors
05/10/2012CA2815280A1 A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium
05/10/2012CA2815084A1 Cdk inhibitors
05/10/2012CA2814534A1 Novel inhibitors of hepatitis c virus
05/10/2012CA2814357A1 Hydrate of 1-{(2s)-2-amino-4-[2,4-bis(trifluoromethyl)-5,8-di- hydropyrido[3,4-d]pyrimidin-7(6h)-yl]-4-oxobutyl}-5,5-difluoro-piperidin-2-one tartrate
05/10/2012CA2814057A1 A combination composition
05/10/2012CA2813849A1 Methods of treating rheumatoid arthritis using il-17 antagonists
05/10/2012CA2813671A1 Pharmaceutical combinations for the treatment of metabolic disorders
05/10/2012CA2812664A1 Use of active pharmaceutical compounds for the treatment of central nervous system conditions
05/10/2012CA2812655A1 Indole derivatives
05/10/2012CA2811948A1 Methods for treatment of brain injury utilizing biologics
05/09/2012EP2450360A2 (S)-N-Methylnaltrexone
05/09/2012EP2450359A2 (R)-N-Methylnaltrexone
05/09/2012EP2450358A1 Fused, tricyclic sulfonamide inhibitors of gamma secretase
05/09/2012EP2450352A1 Prophylactic or therapeutic agent for cancer
05/09/2012EP2450351A1 Lactam compounds and their use as pharmaceuticals
05/09/2012EP2450350A1 3-Pyridinecarboxamide and 2-pyrazinecarboxamide derivatives as HDL-cholesterol raising agents
05/09/2012EP2450349A1 N-(1-phenyl-2-oxo-3-piperidyl)sulphonamide libraries for the identification of biological and pharmacological activity
05/09/2012EP2450347A1 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
05/09/2012EP2450346A1 Antagonists of the TRPV1 receptor and uses thereof
05/09/2012EP2450084A1 Substances having body mass redistribution properties
05/09/2012EP2450051A1 Medicinal agent and method for treatment of intractable chronic hepatitis c
05/09/2012EP2450048A2 Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
05/09/2012EP2450044A1 Difructose anhydride-containing composition for use in inhibiting dental caries
05/09/2012EP2450043A1 Pharmaceutical composition for dermal use to treat psoriasis, sebopsoriasis or seborrhoic dermatitis comprising a vitamin D and a corticosteroid
05/09/2012EP2450042A1 Glucose metabolism-improving agent and glucose metabolism-improving composition
05/09/2012EP2450041A2 Improved testosterone gel and method of use
05/09/2012EP2450040A2 Compositions and kits for treating influenza
05/09/2012EP2450039A1 Dosing regimen for sedation with CNS 7056 (Remimazolam)
05/09/2012EP2450038A1 A pharmaceutical composition for treating diabetic nephropathy and the preparation method and use thereof
05/09/2012EP2450037A1 Methods, compositions and articles of manufacture for contributing to the treatment of cancers
05/09/2012EP2450036A1 Surface anesthetic agent
05/09/2012EP2450035A1 Combination of adapalene and benzoyl peroxide for treating acne lesions
05/09/2012EP2449114A1 Novel lipid formulations for delivery of therapeutic agents to solid tumors
05/09/2012EP2449106A1 Compositions and methods for silencing apolipoprotein b
05/09/2012EP2449105A2 Use of interfering rna for treating an hiv infection
05/09/2012EP2449101A1 Neurotoxins exhibiting shortened biological activity
1 ... 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 ... 7860